Lyka Labs Ltd.

LYKALABS

Market Cap
₹428 Cr.
P/E
0.00

Lyka Labs Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Chances of aggressive revenue recognition - Operating profit of company is not getting converted to cash and recievables rising faster than sales
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company has significant contigent liabilities which can be risky
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years but more due to rerating
ROE
ROE has decreased vs 10 year trend
Working Capital
Working Capital of the company seems to be under control
Debt
Company might have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
-29.07%
3yr Average
102.7%
5yr Average
143.45%
Net Profit Margin
Latest
-14.2%
3yr Average
-2.5%
5yr Average
-22.76%
ROCE
Latest
5.12%
3yr Average
38.38%
5yr Average
20.41%
Debt to Equity
Latest
1.59
3yr Average
1.68
5yr Average
-0.51
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Peer Comparison
Company Filing
Show Previous Years
Discussions & Analysis
timeline